OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IMVT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Immunovant (IMVT) Earnings Date & Reports

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMVT is expected to report earnings to -71 cents per share on October 31

Q3'25

Est.

$-0.72

Q2'25

Missed

by $0.01

Q1'25

Beat

by $0.07

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.15

The last earnings report on August 11 showed earnings per share of -70 cents, missing the estimate of -69 cents. With 461.63K shares outstanding, the current market capitalization sits at 2.52B.

View a ticker or compare two or three

Compare

IMVT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMVT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMVT showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

320 West 37th Street

Phone

+1 917 580-3099

Employees

164

Web

https://www.immunovant.com